Dostarlimab in the treatment of recurrent or primary advanced endometrial cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 30, 2020 Category: Cancer & Oncology Authors: Lawrence Kasherman Soha Ahrari Stephanie Lheureux Source Type: research

In reply to the Letter to the Editor on: telemedicine for cancer patients during COVID-19 pandemic: between threats and opportunities
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 27, 2020 Category: Cancer & Oncology Authors: Ronaldo Elkaddoum Fady Gh Haddad Roland Eid Hampig Raphael Kourie Source Type: research

COVID-19 and breast cancer: may the microbiome be the issue?
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 27, 2020 Category: Cancer & Oncology Authors: Angioletta Lasagna Valentina Zuccaro Elisa Ferraris Marta Corbella Raffaele Bruno Paolo Pedrazzoli Source Type: research

Silver Prussian blue analogue nanomedicine for future cancer therapy
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 27, 2020 Category: Cancer & Oncology Authors: Shagufta Haque Chitta Ranjan Patra Source Type: research

Cave canem: urine is not urine in corona times
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 27, 2020 Category: Cancer & Oncology Authors: Kunz Yannic Horninger Wolfgang Pinggera Germar-Michael Source Type: research

Benefits and limitations of real-world evidence: lessons from EGFR mutation-positive non-small-cell lung cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 26, 2020 Category: Cancer & Oncology Authors: Bassel Nazha James C-H Yang Taofeek K Owonikoko Source Type: research

Cost-utility analysis of selective internal radiation therapy  with Y-90 resin microspheres in hepatocellular carcinoma
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 23, 2020 Category: Cancer & Oncology Authors: Noemi Muszbek Edit Remak Rachel Evans Victoria K Brennan Fabien Colaone Suki Shergill Damian Mullan Paul J Ross Source Type: research

Real-world effectiveness outcomes in patients diagnosed with metastatic triple-negative breast cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 19, 2020 Category: Cancer & Oncology Authors: Karen E Skinner Amin Haiderali Min Huang Lee S Schwartzberg Source Type: research

Estimate of multiple myeloma patients by line of therapy in the US: population-level projections 2020 –2025
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 17, 2020 Category: Cancer & Oncology Authors: Gena Kanas Otavio Clark Katie Keeven Knar Nersesyan Leah Sansbury Cosmina Hogea Source Type: research

Association of clinico-genomic characteristics with tumor mutational burden in small cell lung cancer patients
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 17, 2020 Category: Cancer & Oncology Authors: Sumesh Kachroo Changxia Shao Kaushal Desai Jinghua He Fan Jin Shuvayu Sen Source Type: research

Treatment patterns and clinical outcomes with palbociclib-based therapy received in US community oncology practices
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 10, 2020 Category: Cancer & Oncology Authors: Junji Lin Lynn McRoy Maxine D Fisher Nan Hu Cralen Davis Debanjali Mitra Mark S Walker Source Type: research

First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 10, 2020 Category: Cancer & Oncology Authors: Hyun Cheol Chung Yung-Jue Bang Charles S  Fuchs Shu-Kui Qin Taroh Satoh Kohei Shitara Josep Tabernero Eric van Cutsem Maria Alsina Zhu  Alexander Cao Jia Lu Pooja Bhagia Chie-Schin Shih Yelena Y Janjigian Source Type: research

The patient ’s perspective on treatment with dacomitinib: patient-reported outcomes from the Phase III trial ARCHER 1050
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 9, 2020 Category: Cancer & Oncology Authors: Jean Paty Rickard Sandin Arlene Reisman Yi-Long Wu Maria Rita Migliorino Xiangdong Zhou Ying Cheng Ki Hyeong Lee Kazuhiko Nakagawa Seiji Niho Jes ús Corral Adam P łużański Rolf Linke Oren Meyers Tony S Mok Source Type: research

Phase III study of selpercatinib vs chemotherapy +/ − pembrolizumab in untreated RET positive non-small-cell lung cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 5, 2020 Category: Cancer & Oncology Authors: Benjamin J Solomon Cai Cun Zhou Alexander Drilon Keunchil Park J ürgen Wolf Yasir Elamin Hannah M Davis Victoria Soldatenkova Andreas Sashegyi Aimee Bence Lin Boris K Lin Herbert H F Loong Silvia Novello Edurne Arriola Maurice P érol Koichi Goto Fernand Source Type: research

Nanotechnology-based platforms to improve immune checkpoint blockade efficacy in cancer therapy
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 2, 2020 Category: Cancer & Oncology Authors: Deeksha G  Lahori Pegah Varamini Source Type: research

Immunotherapy and potential predictive biomarkers in the treatment  of neuroendocrine neoplasia
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 2, 2020 Category: Cancer & Oncology Authors: Guanghui Xu Yuhao Wang Hushan Zhang Xueke She Jianjun Yang Source Type: research

Incorporating teleoncology practices in the undergraduate medical curriculum
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 1, 2020 Category: Cancer & Oncology Authors: Anna Maria Wozniak Kathrine Sofia Rallis Source Type: research

Real-world practice patterns and outcomes in Veterans with relapsed/refractory diffuse large B-cell lymphoma
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 29, 2020 Category: Cancer & Oncology Authors: Sophia H-C Chien Deborah Morreall Vikas Patil Kelli M Rasmussen Catherine Li Christina M Yong Zachary Burningham Anthony Masaquel Mary Halloran Elisha De  Long-Sieg Mathias Schulz Brian C Sauer Ahmad S Halwani Source Type: research

Lamin B1 promotes tumor progression and metastasis in primary prostate cancer patients
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 28, 2020 Category: Cancer & Oncology Authors: Fei Luo Jiaxi Han Yatong Chen Kuo Yang Zhihua Zhang Jian Li Source Type: research

Effective combinations of radiotherapy and immunotherapy in the treatment of esophageal squamous cell carcinoma
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 27, 2020 Category: Cancer & Oncology Authors: Yang Yang Hong Ge Source Type: research

Optimizing therapy sequence to prevent patient attrition in EGFR mutation-positive advanced or metastatic NSCLC
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 23, 2020 Category: Cancer & Oncology Authors: Julia Roeper Sylke Kurz Christian Groh é Frank Griesinger Source Type: research

First-line immunotherapy versus targeted therapy in patients with BRAF-mutant advanced melanoma: a real-world analysis
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 21, 2020 Category: Cancer & Oncology Authors: Anna C Pavlick Ruizhi Zhao Cho-Han Lee Corey Ritchings Sumati Rao Source Type: research

Real-world outcomes associated with liposomal irinotecan dose reductions in metastatic pancreatic ductal adenocarcinoma
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 19, 2020 Category: Cancer & Oncology Authors: George P Kim Andy Surinach Frank A Corvino Paul Cockrum Bruce Belanger Laith Abushahin Source Type: research

Evolving use of real-world evidence in the regulatory process: a focus on immuno-oncology treatment and outcomes
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 19, 2020 Category: Cancer & Oncology Authors: John C O ’Donnell T  Kim Le Radu Dobrin Mitch Higashi Ashley Pereira Samuel Wagner Arvin Yang Mathias Hukkelhoven Source Type: research

Erratum
Future Oncology,Volume 16, Issue 29, Page 2371-2371, October 2020. (Source: Future Oncology)
Source: Future Oncology - October 19, 2020 Category: Cancer & Oncology Source Type: research

The future of colorectal cancer research: an interview with Hans Schmoll
Future Oncology,Volume 16, Issue 29, Page 2269-2271, October 2020. (Source: Future Oncology)
Source: Future Oncology - October 17, 2020 Category: Cancer & Oncology Authors: Hans-Joachim Schmoll Source Type: research

The future of colorectal cancer research: an interview with
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 17, 2020 Category: Cancer & Oncology Authors: Hans-Joachim Schmoll Source Type: research

An update of venetoclax and obinutuzumab in chronic lymphocytic leukemia
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 16, 2020 Category: Cancer & Oncology Authors: Ross Salvaris Stephen Opat Source Type: research

Comparative efficacy of cemiplimab versus other systemic treatments for advanced cutaneous squamous cell carcinoma
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 14, 2020 Category: Cancer & Oncology Authors: Sam Keeping Yingxin Xu Chieh-I Chen Shannon Cope Ali Mojebi Andreas Kuznik Gerasimos Konidaris Dieter Ayers Medha Sasane Rachel Allen Thi-Minh-Thao Huynh Evan Popoff Morganna Freeman Michael L Andria Matthew G Fury Kanwarjit Singh Eggert Stockfleth Amarna Source Type: research

Next-generation sequencing of circulating tumor DNA for metastatic non-small cell lung cancer: a discussion on its implementation in the Brazilian clinical practice
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 14, 2020 Category: Cancer & Oncology Authors: Luiz H  Araujo Carlos Gil Ferreira Clarissa S Baldotto Clarissa Mathias Gilberto Castro Renata Coudry Source Type: research

Syt-7 overexpression predicts poor prognosis and promotes cell proliferation in hepatocellular carcinoma
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 14, 2020 Category: Cancer & Oncology Authors: Hao Jin Qing Pang Meifang Fang Yong Wang Zhongran Man Yi Tan Huichun Liu Source Type: research

Targeting FGFR2 in advanced cholangiocarcinoma: an interview with Arndt Vogel
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 13, 2020 Category: Cancer & Oncology Authors: Arndt Vogel Source Type: research

High preoperative levels of circulating SFRP5 predict better prognosis in colorectal cancer patients
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 13, 2020 Category: Cancer & Oncology Authors: Chandra Kirana Eric Smith Doan T Ngo Markus I Trochsler Peter J Hewett Richard S Stubbs Jennifer E Hardingham Guy J Maddern Ehud Hauben Source Type: research

Pemigatinib, a potent inhibitor of FGFRs for the treatment of cholangiocarcinoma
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 9, 2020 Category: Cancer & Oncology Authors: Valeria Merz Camilla Zecchetto Davide Melisi Source Type: research

Exploratory analysis of the platelet-to-lymphocyte ratio prognostic value in the adjuvant renal cell cancer setting
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 8, 2020 Category: Cancer & Oncology Authors: Anup Patel Alain Ravaud Robert J Motzer Allan J Pantuck Michael Staehler Bernard Escudier Jean-Fran çois Martini Mariajose Lechuga Xun Lin Daniel J George Source Type: research

Comparative effectiveness study of chemotherapy in follicular lymphoma patients in the rituximab era: a Japanese claims database study
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 5, 2020 Category: Cancer & Oncology Authors: Saaya Tsutsu é Kensei Tobinai Jingbo Yi Bruce Crawford Source Type: research

Integrating the melanoma 31-gene expression profile test to surgical oncology practice within national guideline and staging recommendations
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 5, 2020 Category: Cancer & Oncology Authors: David M Hyams Kyle R Covington Clare E Johnson Kristen M Plasseraud Robert W Cook Source Type: research

Effect of comorbidities/comedications on sunitinib outcomes for metastatic renal cell carcinoma: the STAR-TOR registry
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 5, 2020 Category: Cancer & Oncology Authors: Martin Boegemann Katrin Schlack Michael Rink Stephan Bernhardt Michael Moran Marcus Hubbe Lothar Bergmann Marianne Schmid Arne Strauss Source Type: research

Pembrolizumab plus axitinib combination and the paradigm change in the treatment of advanced renal cell carcinoma
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 4, 2020 Category: Cancer & Oncology Authors: Martina Spisarov á Bohuslav Melichar Denisa Vit ásková Hana Študentová Source Type: research

Healthcare utilization and total costs of care among patients with advanced metastatic gastric and esophageal cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - September 29, 2020 Category: Cancer & Oncology Authors: Pranav Abraham Liya Wang Zhengzheng Jiang Joseph Gricar Hiangkiat Tan Ronan J Kelly Source Type: research

Development of a prognostic model based on an immunogenomic landscape analysis of colorectal cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - September 29, 2020 Category: Cancer & Oncology Authors: HJ Li YL Wang L Ming XQ Guo YL Li JC Wang YQ Zhang L Cheng Source Type: research

Liquid biopsy for ALK-positive early non-small-cell lung cancer predicts disease relapse
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - September 28, 2020 Category: Cancer & Oncology Authors: Ji Li Wen Dong Li Na Liu Yi Jiang Huang Mei Fang Xiao Source Type: research

A Phase III study of zanubrutinib plus rituximab versus bendamustine plus rituximab in transplant-ineligible, untreated mantle cell lymphoma
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - September 27, 2020 Category: Cancer & Oncology Authors: Martin Dreyling Constantine S Tam Michael Wang Stephen D Smith Marco Ladetto Huiqiang Huang William Novotny Melannie Co Alfredo Romano Eric Holmgren Jane Huang Steven Le Gouill Source Type: research

Brigatinib in ALK-positive non-small cell lung cancer: real-world data in the Latin American population (Bri-world extend CLICaP)
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - September 27, 2020 Category: Cancer & Oncology Authors: David Heredia Feliciano Barr ón Andr és F. Cardona Saul Campos Jer ónimo Rodriguez-Cid Luis Martinez-Barrera Jorge Alatorre Miguel Ángel Salinas Luis Lara-Mejia Diana Flores-Estrada Oscar Arrieta Source Type: research

Long noncoding RNA ANRIL as a novel biomarker in human cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - September 27, 2020 Category: Cancer & Oncology Authors: Ning Lou Guohong Liu Yunbao Pan Source Type: research

A theoretical model of financial burden after cancer diagnosis
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - September 24, 2020 Category: Cancer & Oncology Authors: Salene MW Jones Nora B Henrikson Laura Panattoni Karen L Syrjala Veena Shankaran Source Type: research

Demographic factors associated with missed follow-up among solid tumor patients treated at a large multi-site academic institution
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - September 24, 2020 Category: Cancer & Oncology Authors: Samantha L Freije Jordan A Holmes Saleh Rachidi Susannah G Ellsworth Richard C Zellars Tim Lautenschlaeger Source Type: research

Clinical applications of circulating tumor DNA in monitoring breast cancer drug resistance
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - September 24, 2020 Category: Cancer & Oncology Authors: Yang Liu Qian Du Dan Sun Ruiying Han Mengmeng Teng Siying Chen Haisheng You Yalin Dong Source Type: research

Role of indoleamine 2,3-dioxygenase in acute myeloid leukemia
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - September 24, 2020 Category: Cancer & Oncology Authors: Philip T Sobash Ravindra Kolhe Nagla Abdel Karim Achuta K Guddati Anand Jillella Vamsi Kota Source Type: research

Gilteritinib use in the treatment of relapsed or refractory acute myeloid leukemia with a FLT3 mutation
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - September 24, 2020 Category: Cancer & Oncology Authors: Octavio Ballesta-L ópez Antonio Solana-Altabella Juan Eduardo Meg ías-Vericat David Mart ínez-Cuadrón Pau Montesinos Source Type: research